Comparing the rectal Indomethacin plus vitamin C injection versus rectal indomethacin on prevention of post ERCP pancreatitis

Phase 4

• Conditions: pancreatitis.; Other acute pancreatitis; K85.8

• Registration Number: IRCT20121021011192N11
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 280

Inclusion Criteria

Patients undergoing ERCP in Taleghani hospital by taking written consent

Exclusion Criteria

Patients history of hypersensitivity against each of indomethacin or vitamin C
Active peptic ulcer diseases
Renal impairment (GFR < 10 ml/min)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pancreatitis. Timepoint: 10 days after doing ERCP. Method of measurement: clinical evaluation.

Secondary Outcome Measures

Name	Time	Method
Gastrointestinal bleeding. Timepoint: 10 days after doing ERCP. Method of measurement: Clinical observation.